KARE Biosciences
A biotechnology company dedicated to repurposing drugs and developing supplements to address unmet needs in a variety of medical areas. The COVID-19 pandemic made apparent the gaps in our therapeutic arsenal that KARE Biosciences aims to strengthen. The company is currently working on a multivitamin (KidneyVite) to meet all the nutritional needs of kidney patients, and a drug (Ramatroban) to treat COVID-19, sickle cell disease, cardiovascular disease, neurological diseases, obesity and more.
KARE Biosciences
Address: 2505 Seascape Dr, Nevada 89128
Phone: +1 (562)412-6259
Fax: +1 (702)974-1001
Email: ajay.gupta@karebio.com
Dr. Ajay Gupta outlines the key mechanisms driving COVID-19 &
comments on the government's response to the pandemic
Dr. Ajay Gupta unveils the role of thromboxane A2 storm in COVID-19
Professor at the University of California Irvine, School of Medicine, Division of Nephrology, Hypertension and Kidney Transplantation
Sign up to hear from us.
Please send us a message or call us for more information.
Feel free to fax any documents to +1 (702)974-1001
Monday-Sunday: 6:00am - 9:00pm